Anthropic's Mega-Round Closes Near $1T: What the Numbers Mean

Anthropic has closed what appears to be the largest private funding round in history, and secondary market traders are already pricing the company at a trillion dollars. The gap between those two figures deserves scrutiny.

Key points

• Anthropic raised $65 billion in private funding, pushing its primary-round valuation to $965 billion.
• That figure is up sharply from the greater-than-$900 billion valuation and $30-plus billion raise reported by Bloomberg as recently as May 22.
• In the secondary market, common stock is already trading on forward contracts at an implied $1 trillion valuation, according to analyst Om Malik.
• Quarterly revenue has doubled, per earlier reporting, but Anthropic has not disclosed absolute revenue figures publicly.
• The spread between the primary round price ($965B) and secondary market pricing ($1T) signals strong demand, but also raises questions about liquidity and price discovery.

How the round grew so fast

Earlier coverage on this site (May 3 and May 10) tracked this round from a reported $500 billion valuation target through $900 billion and now to $965 billion at close. The jump from the May 22 Bloomberg report to the final close represents roughly a $65 billion increase in valuation in under a week. That kind of upward drift during a round’s final stages typically reflects either oversubscription, late entrants accepting a higher price to get allocation, or both. Anthropic has not commented publicly on which institutional investors anchored the final close or what the capital is earmarked for.

What is the secondary market signaling?

Om Malik wrote this week that he received an unsolicited offer to buy $10 million of Anthropic common stock as a forward contract at a $1 trillion valuation. His reaction, stated plainly, was that this looks like a bubble. That is a meaningful data point. Secondary market transactions in common stock are structurally different from primary preferred-share rounds: they carry no liquidation preferences, no anti-dilution protections, and in Anthropic’s case likely face transfer restrictions. Paying a premium above the primary round price for common stock, in forward-contract form, implies either very high conviction on an IPO or acquisition at a substantial markup, or simply that demand is outrunning rational price anchors.

The “numbers problem” Malik identifies is not just about valuation inflation. It is about the difficulty of grounding these figures in verifiable fundamentals. Anthropic’s revenue has doubled quarter-over-quarter, which is genuinely impressive, but the base number remains undisclosed. A company doubling from $500 million annually looks very different from one doubling from $2 billion. Without that anchor, the $965 billion valuation is essentially a bet on continued hypergrowth and a future liquidity event.

What this means for an eventual IPO

For investors watching Anthropic’s path to public markets, the closing of this round at $965 billion matters in a few specific ways. First, it sets a high bar: a public offering would need to price at or above this level to avoid handing late private investors a down round on paper. Second, the sheer size of the raise ($65 billion) suggests Anthropic is not imminently capital-constrained, which could push an IPO timeline further out. Companies that can raise at will in private markets have less urgency to absorb the disclosure requirements and quarterly earnings pressure of being public. Third, the secondary market activity at $1 trillion suggests there is retail and institutional appetite that the private market cannot fully satisfy, which is historically a precondition for a successful public offering.

None of this is a timeline. Anthropic has made no public statements about IPO plans. But the structure of this round, its size, its valuation, and the secondary market premium above it, collectively describe a company that the market is treating as pre-IPO even if the company itself is not.

A note on what we do not know

The sources available this week confirm the $65 billion raise and $965 billion valuation, and provide one credible secondary market data point at $1 trillion. They do not confirm the identity of lead investors, the use of proceeds, the company’s current annualized revenue, or any timeline for a liquidity event. Readers should treat the valuation figures as market-clearing prices in a specific moment, not as fundamental appraisals.